Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters








Database
Language
Publication year range
1.
Nat Commun ; 12(1): 256, 2021 01 11.
Article in English | MEDLINE | ID: mdl-33431871

ABSTRACT

In humans, inactivating mutations in MLL4, which encodes a histone H3-lysine 4-methyltransferase, lead to Kabuki syndrome (KS). While dwarfism is a cardinal feature of KS, the underlying etiology remains unclear. Here we report that Mll4 regulates the development of growth hormone-releasing hormone (GHRH)-producing neurons in the mouse hypothalamus. Our two Mll4 mutant mouse models exhibit dwarfism phenotype and impairment of the developmental programs for GHRH-neurons. Our ChIP-seq analysis reveals that, in the developing mouse hypothalamus, Mll4 interacts with the transcription factor Nrf1 to trigger the expression of GHRH-neuronal genes. Interestingly, the deficiency of Mll4 results in a marked reduction of histone marks of active transcription, while treatment with the histone deacetylase inhibitor AR-42 rescues the histone mark signature and restores GHRH-neuronal production in Mll4 mutant mice. Our results suggest that the developmental dysregulation of Mll4-directed epigenetic control of transcription plays a role in the development of GHRH-neurons and dwarfism phenotype in mice.


Subject(s)
Growth Hormone-Releasing Hormone/biosynthesis , Histone-Lysine N-Methyltransferase/metabolism , Hypothalamus/cytology , Neurons/metabolism , Animals , Base Sequence , Dwarfism/metabolism , Embryo, Mammalian/metabolism , Epigenesis, Genetic , Gene Expression Regulation, Developmental , HEK293 Cells , Humans , Hypothalamus/embryology , Male , Mice, Knockout , Models, Biological , Nuclear Respiratory Factor 1/metabolism , Phenylbutyrates/pharmacology , Transcription Factors/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL